7:30 am

Continental Breakfast

8:00 am

Welcome and Opening Remarks

Ruemu E. Birhiray, MD - Chair

Director of Bone Marrow Transplantation

St. Vincent Hospital

Hematology-Oncology of Indiana

Indianapolis, Indiana

Michael C. Wiemann, MD - Co-Chair

Senior Vice President and Chief Medical Officer

Providence Hospital/St. John Health

Warren, Michigan

8:15 am

Acute Myelogenous Leukemia, Acute Promyelocytic Leukemia

Martin S. Tallman, MD

Chief, Leukemia Service

Memorial Sloan-Kettering Cancer Center

Weill Cornell Medical College

New York, New York

8:45 am

Chronic Myelogenous Leukemia

Charles A. Schiffer, MD

Professor of Medicine and Oncology

Director of the Leukemia/Lymphoma Multidisciplinary Program

Wayne State University School of Medicine

Karmanos Cancer Institute

Detroit, Michigan

9:15 am

Chronic Lymphocytic Leukemia

Michael J. Keating, MB, BS

Professor of Medicine, Department of Leukemia, Division of Cancer Medicine

MD Anderson Cancer Center

The University of Texas

Houston, Texas

9:45 am

Panel Discussion

10:00 am

Break

10:15 am

Benign Hematology

Craig M. Kessler, MD

Chief, Division of Hematology/Oncology

Lombardi Comprehensive Cancer Center

Professor of Medicine

Georgetown University Medical Center

Washington, District of Columbia

10:45 am

Myelodysplastic Syndromes

Richard M. Stone, MD

Director, Adult Leukemia Program

Dana-Farber Cancer Institute

Attending Physician

Brigham and Women's Hospital

Professor of Medicine

Harvard Medical School

Boston, Massachusetts

11:15 am

Myeloproliferative Disorders

Ayalew Tefferi, MD

Professor of Hematology and Internal Medicine

Mayo Clinic

Rochester, Minnesota

11:45 am

Keynote Address: Multiple Myeloma

Kenneth C. Anderson, MD

Kraft Family Professor of Medicine

Harvard Medical School

Chief, Division of Hematologic Neoplasia

Dana-Farber Cancer Institute

Boston, Massachusetts

12:30 pm

Lunch

1:15 pm

Indolent Plasma Cell Disorders and Amyloidosis

C. Ola Landgren, MD, PhD

Head, Multiple Myeloma Section

Senior Investigator

National Cancer Institute

Bethesda, Maryland

1:45 pm

Indolent B-cell Lymphomas

Myron S. Czuczman, MD

Professor of Medicine

Chief, Lymphoma/Myeloma Service

Head, Lymphoma Transitional Research Laboratory

Roswell Park Cancer Institute

 Buffalo, New York

2:15 pm

Aggressive B-cell Lymphomas

Richard I. Fisher, MD

Sam Durand Professor of Medicine

Director, Division of Hematology/Oncology

Director, Jam Wilmot Cancer Center

CEO, University of Rochester Medical Faculty Group

Senior Associate Dean for Clinical Affairs, School of Medicine and Dentistry

Vice President, University of Rochester Medical Center

Rochester, New York

2:45 pm

Stem Cell Transplant

Richard W. Childs, MD, CMDR, USPHS

Senior Clinical Investigator

Hematology Branch of the National Heart, Lung, and Blood Institute

National Institutes of Health

Bethesda, Maryland

3:15 pm

Panel Discussion

3:30 pm

Closing Remarks

3:45 pm

Adjourn